Cystic Fibrosis drugs to cost €400 million over ten years

The deal to provide life-changing drugs to cystic fibrosis sufferers will cost the state close to €400 million over ten years.

The HSE and the drug’s maker Vertex have reached a deal in principle on providing the drugs Orkambi and Kalydeco to CF patients, but the final terms and conditions are still being worked out.

The final cost will be approved by ministers at a cabinet meeting before the end of the month, ...